Clinical Trial Update: Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial [Phase 2]

View source ↗

Summary

Pilot phase 2 trial evaluating nicotinamide for prevention of skin cancer in transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Non-melanoma Skin Cancer
• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Women's College Hospital | Conditions: Non-melanoma Skin Cancer, Carcinoma, Squamous Cell | Phase 2 | Status: UNKNOWN